CME-Directory

A three-day live conference for physicians and sonographers that covers the most current and relevant topics in OB-GYN ultrasound. View full conference details and register online at http://www.worldclasscme.com.

View full course details and register online at http://www.worldclasscme.com. Attend the Nuchal Translucency Course on Sunday, September 20 and the Advanced OB-GYN Ultrasound Seminar September 20-22, 2009. AMA PRA Category 1 and ASRT approved for: Nuchal Translucency Course - 4.5 credits Adv OB-GYN Ultrasound - 14.75 credits Entire Course - 19.25 credits Course Objectives Upon completion of this conference, the participant will be able to: * Describe state-of-the-art practice in prenatal genetic screening * Know how to perform nuchal translucency measurements * Understand the expanding role of 3D ultrasound in obstetrical and gynecological diagnosis * Diagnose fetal heart abnormalities * Improve his/her skills in diagnosis of fetal anomalies

Not yet ready to be a cosmetic doctor but still want to make a decent and honest living as a gynecologist? This practical course stresses how to enhance your day-to-day office GYN practice with relevant, important procedures adn therapies that are easy to master, comfortable to incorporate and solidly reimbursable. Upgrade your skills adn clinical approach to meet the needs of your gynecologic patients for the 21st century. Feel good about offering comprehensive, up-to-date information and services that will expand your gynecologic practice while making it more enjoyable and rewarding for you. Whether in a solo or a group practice, this course will change the way you practice medicine. View full conference details and register online at http://www.worldclasscme.com. Course Objectives Upon completion of this conference, the participant will be able to: • Incorporate transvaginal ultrasound into his or her routine (including early pregnancy with bleeding and abnormal uterine bleeding) • Perform, interpret, and coordinate saline infusion sonohysterography into their practice • Read and interpret DXA scans • Determine who and how to treat for osteoporotic fracture reduction • Assess breast cancer risk and detail how to reduce it • Analyze the complex but still important role for HT in the menopausal transition • Detail new advances in hormonal contraception • Quantify various delivery systems and doses of HT and their risks and benefits • Set up an in-office program of urodynamic, and biofeedback testing • Describe how to utilize and implement pelvic floor rehabilitation in a GYN office setting • Decide if office endometrial ablation and transcornual sterilization are feasible • Treat overactive bladder and pelvic floor dysfunction • Evaluate the role of cervical cytology: past, present, and future • Detail HPV testing and vaccines • Understand the use of ovarian reserve testing and when to refer patients for assisted reproductive technologies (ART) Course Objectives (subject to revision) Upon completion of this conference, the participant will be able to: • Incorporate transvaginal ultrasound into his or her routine (including early pregnancy with bleeding and abnormal uterine bleeding) • Perform, interpret, and coordinate saline infusion sonohysterography into their practice • Read and interpret DXA scans • Determine who and how to treat for osteoporotic fracture reduction • Assess breast cancer risk and detail how to reduce it • Analyze the complex but still important role for HT in the menopausal transition • Detail new advances in hormonal contraception • Quantify various delivery systems and doses of HT and their risks and benefits • Set up an in-office program of urodynamic, and biofeedback testing • Describe how to utilize and implement pelvic floor rehabilitation in a GYN office setting • Decide if office endometrial ablation and transcornual sterilization are feasible • Treat overactive bladder and pelvic floor dysfunction • Evaluate the role of cervical cytology: past, present, and future • Detail HPV testing and vaccines • Understand the use of ovarian reserve testing and when to refer patients for assisted reproductive technologies (ART)